<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Currently, most of the COVID-19 therapeutic drugs are in ongoing clinical trials and remain pre-approval access. Combining the available evidence, clinical experience and patientsâ€™ individual characteristics, providing patients with evidence-based treatment and care is of great significance. As a member of healthcare professionals, hospital pharmacists should give full play to the specialty of pharmacy, and fully combine clinical guidance and clinical research to assist clinicians in formulating and adjusting the medication regimens for hospitalized patients with COVID-19.</p>
